Replies to post #11222 on Marker Therapeutics Inc (MRKR)

[tpizzazz24]

I see that Merck has some partnerships with the use of Keytruda that are structured this way.
I think the terms of the partnership should reflect how good our science is being viewed by BP.
I'm with you all the way T. Want front end money, royalties, and it would be nice if they helped foot the bill.
I think we will eventually see multiple partnerships down the road.
Hopefully we see some nice P2 data released through 2016 with other trial to begin by years end.